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Abstract 
The Adjusted Research Excellence Index is a composite indicator selected by the 
European Research Area Council (ERAC) as the headline measure to monitor country 
performance with respect to ERA Roadmap Priority 1, ‘Effective national research 
systems’ (European Commission, 2017). It combines four dimensions that characterize 
effective research systems, in terms of scientific and technological research excellence 
(the “production” of high-impact publications and valued patents), and the ability of 
institutes to attract outstanding research grants and participate in researcher exchanges 
to pave the way for future excellence and develop efficient research capacity. This report 
describes the methodology used to compute the latest scores for 43 countries (EU 
Member States and Horizon 2020 Associated Countries) and the EU28 for 4 time points: 
2016, 2013, 2011 and 2010. The results show that Switzerland excels in having the 
most effective national research system, followed by Denmark, the Netherlands, Sweden 
and the United Kingdom. Most of the countries show a welcome growth of the composite 
score over the last period, however it is important to keep in mind that growth is, to a 
large extent, driven by the overall increase in the value of ERC grants. Country ranks 
were found to be rather robust, with uncertainty in the modelling choices having only 
limited impact (3-4 rank positions shifts) on the ranks of the majority of the countries. 
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1 Introduction 
The Adjusted Research Excellence Index is a composite indicator selected by the 
European Research Area Council (ERAC) as the headline measure to monitor country 
performance with respect to ERA Roadmap Priority 1, ‘Effective national research 
systems’ (European Commission, 2017a,b). It combines four dimensions that 
characterize effective research systems, in terms of scientific and technological research 
excellence (the “production” of high-impact publications and valued patents), and the 
ability of institutes to attract outstanding research grants and participate in researcher 
exchanges to pave the way for future excellence and develop efficient research capacity. 
The four dimensions are defined [and henceforth referred to] as:  
 The share of top 10 % most highly cited publications per total publications 
[HICIT] 
 PCT patent applications per population [PCT] 
 ERC grants per public R&D [ERC], and  
 Participation in Marie Skłodowska-Curie actions: the number of MSCA researchers 
hosted per national MSCA researcher) [MSCA]; 
This brief report presents the latest scores for 43 countries (EU Member States and 
Horizon 2020 Associated Countries) and the EU28 total for the purposes of the upcoming 
ERA Progress Report. In order to monitor progress over time, scores were produced 
using the most recently available data (2016), as well as using historical data for earlier 
time points (2010 and 2013). It thus updates the scores and trends published in the ERA 
Progress Report 2016. 
The focus of this report are the methodological aspects of computing the Adjusted 
Research Excellence Index (AREI), which should be seen as complementary to the more 
comprehensive discussions of research performance at the level of countries and the EU, 
which is provided in the ERA Progress Report. The definition and quantification of the 
concept of scientific and technological research excellence, or its impact – which 
continues to be at the focus of scholarly attention – remains outside the scope of this 
methodology report.1 
The AREI, as any composite indicator, aims to provide the “big picture” with respect to 
the phenomenon of interest in the form of a summary score. Users of the index are 
invited to explore not merely the aggregate scores and ranking of countries, but also 
scores of the underlying components (as two countries may achieve a similar score by 
having a different distribution of strengths and weaknesses) as well as the measurable 
uncertainty in the modelling choice that may influence the aggregate ranking. This 
report, therefore, goes beyond merely presenting the aggregation methods and 
aggregate scores; the robustness section (3.2) also presents the outcomes of the 
uncertainty analysis, which should help users a richer understanding of how countries 
compare with one another in terms of scientific and technological research excellence, 
and what are the trends over time.  
  
                                           
1 For a more detailed discussion on the complexities related to the conceptualization and measurement of 
scientific and technological research excellence, see, among others, Tijssen (2003), Hardeman et al 
(2013), Sorensen et al (2016), or Ferretti et al (2018). 
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2 Methods and comparability with previous editions 
The methodology to compute the Adjusted Research Excellence Index is presented in 
Vértesy (2015) and is rooted in that of a previous version of the Research Excellence 
Index developed by the JRC. As some refinements were necessary due to data 
availability and changes in definition of the source variable, the steps taken to compute 
the indicator (following OECD-JRC 2008) are described below. 
 
Table 1 Collection of data from multiple sources and multiple time points 
Component Numerator Denominator Sources Sources Detailed 
HICIT Nr. of publications 
among the top 10% 
most highly cited (field 
normalized) 
Total nr. of 
publications 
CWTS CWTS, Leiden (and SciVal 
for AM, GE, TN) 
PCT PCT patent applications 
by inventor country 
and priority year 
Total Population OECD, 
World 
Bank 
OECD_MSTI, OECD_PATS, 
OECD REGPAT microdata 
(AL, ME, RS), World Bank 
World Development 
Indicators 
ERC Total value of ERC 
grants received by host 
organization in a 
country; (multi-year 
programmes spread 
equally between start 
and end dates) 
Public R&D 
(GOVRD+HERD, 
constant Eurs 
PPS) 
DG RTD, 
Eurostat, 
OECD 
Special tabulation from 
Horizon 2020 and FP7 
Corda data; 
rd_e_gerdfund (OECD 
data for IL) 
MSCA Nr. of MSCA 
researchers hosted  
Nr. nationals 
participating in 
MSCA  
DG EAC Marie Skłodowska-Curie 
Action statistics / country 
fiches, multiple editions2 
 
1. Data collection: The data sources are described in Table 1. In case data was 
missing, figures available for the same country from a neighboring year was 
used. Data was initially also collected for OECD and BRICS countries, however, it 
was not used in this calculation due to issues of comparability (ERC and MSCA 
only meaningful for countries that are part of ERA or associated to Horizon 2020). 
As a result, scores could be computed for all EU Member States and H2020 
Associated countries, with the exception of the Feroer Islands and Liechtenstein 
(due to restrictions of data availability and comparability).  
Considering the joint availability of data for the four components across time, four 
time points were identified for which scores could be computed to meet a fair 
balance between principles of timeliness and alignment of indicators to the same 
year. The two main issues addressed were 1) the lag in the HICIT and PCT scores 
due to citation window and administrative issues of patenting (last available year: 
2015); and the 2) unavailability of comparable MSCA scores between country fact 
sheets released in 2014 and mid-2018. As a compromise, HICIT and PCT scores 
were “shifted ahead” by 1 year (so that actual 2015 scores represent the 2016 
“nominal” values, and so forth), and MSCA figures were shifted back by 1.5 years 
(thus mid-2018 scores represent 2016). Considering also the fact that ERC and 
MSCA were introduced with FP7 and the frequency of MSCA data availability, the 
four time points for which comparable scores could be computed were identified 
as: 2010, 2011, 2013 and 2016. The Appendix provides a detailed overview of 
the original indicator values, as well as the actual and nominal years used. 
Descriptive statistics on the variables are available in Table 3. 
 
                                           
2 URL: https://ec.europa.eu/research/mariecurieactions/msca-numbers_en (retrieved: Jul 2018 and Apr 2016) 
5 
 
2. Treatment of outliers: outliers were detected for indicators that showed 
absolute skewness and kurtosis for the pooled dataset of 220 country-year 
observations (including OECD and BRICS countries discarded subsequently) 
above the threshold values of 2.2 and 3.5, respectively – in the case of ERC and 
MSCA. Outliers were treated by winsorization, a method identified as the one 
causing the least intervention to actual data points. As a result, 6 values were 
adjusted for ERC (affecting IL, CY, UK, CH at various time points), and 4 values 
for MSCA (LU and CH). 
 
3. Normalization of data: for each variable, the pooled dataset of all country-year 
combinations were normalized using the min-max method to obtain a comparable 
range of 10-100 using the formula below. (The minimum was set to 10 rather 
than 0 in order to accommodate the geometric aggregation.) Data was pooled for 
multiple years in order to be able to measure trend over time. 
𝐼𝑞𝑐 =
𝑥𝑞𝑐 −min𝑐 ⁡(𝑥𝑞)
max𝑐(𝑥𝑞) − min𝑐 ⁡(𝑥𝑞)
∗ 90 + 10 (1) 
Where xqc is the value of a component variable q for a country c. The normalized 
scores for each country and indicator are available in the Appendix. 
 
4. Multivariate statistical analyses were performed to test the correlation 
between the components and the presence of a single latent dimension. A strong, 
positive correlation and the presence of a single latent dimension were in fact 
found, similar to past years’ results. The details of the findings of the principal 
component analysis (PCA) and correlation table are available in the ‘Robustness’ 
section 3.2 below. 
 
5. Aggregation of country scores: the 2018 Adjusted Research Excellence Index 
scores were computed by taking the geometric mean (with equal weights) of the 
four normalized components. This method does not allow full compensation of 
relatively weaker performance in one component with strong performance in 
another one, but encourages countries to address bottlenecks.  
 
6. Finally, sensitivity and robustness analyses were carried out to identify the 
statistical relationship between the components and the composite, and to test 
the impact of modelling choices on country rankings.  
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3 Results 
The resulting composite scores are reported in Figure 1 for 44 countries (EU Member 
States, Horizon 2020 Associated Countries and the EU28) for three time points, and in 
Table 2 for all time points. Results show that Switzerland excels in having the most 
effective national research system, followed by Denmark, the Netherlands, Sweden and 
the United Kingdom.  
Most of the countries show a welcome growth of the composite score over the last 
period, however, it is important to keep in mind that growth is largely driven by the 
overall increase in the value of ERC grants. Three of the countries, Greece, Bosnia and 
Herzegovina and Montenegro show a slight decline in scores the last period. (Note that 
the decline for Switzerland should be read with caution and not considered as a warning 
sign, as this may be affected by the outlier treatment.) 
Scores for the individual components are shown in the Appendix. 
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Table 2 Adjusted Research Excellence Scores, “2018” 
Group Country Code 2010 2011 2013 2016 
CAGR over  
past 3 years 
EU28 EU-28 EU28 33.7 36.5 41.0 45.0 3% 
  Austria AT 39.3 41.6 43.5 54.9 8% 
  Belgium BE 37.8 42.5 51.1 55.8 3% 
  Bulgaria BG 16.7 17.2 16.7 16.6 0% 
  Cyprus CY 27.6 29.2 33.7 37.1 3% 
  Czech Republic CZ 20.8 21.1 21.1 23.2 3% 
  Germany DE 38.2 42.8 46.5 50.3 3% 
  Denmark DK 49.5 53.9 64.0 78.6 7% 
  Estonia EE 22.7 25.4 26.6 30.4 5% 
  Greece EL 23.4 23.9 26.6 25.2 -2% 
  Spain ES 26.7 29.0 31.7 35.1 4% 
  Finland FI 41.9 44.9 50.5 54.9 3% 
  France FR 35.2 38.0 42.3 46.6 3% 
  Hungary HU 24.0 26.0 28.3 31.4 4% 
  Croatia HR 14.5 14.3 15.5 19.1 7% 
  Ireland IE 32.0 35.9 43.1 52.9 7% 
  Italy IT 26.5 28.6 30.9 34.4 4% 
  Lithuania LT 16.2 17.3 14.7 16.7 4% 
  Luxembourg LU 27.7 38.7 43.5 57.5 10% 
  Latvia LV 16.0 15.5 17.8 19.6 3% 
  Malta MT 13.6 16.8 17.2 27.8 17% 
  Netherlands NL 50.6 52.3 65.1 74.5 5% 
  Poland PL 15.5 15.6 16.6 18.7 4% 
  Portugal PT 22.3 23.7 25.3 30.1 6% 
  Romania RO 14.3 14.1 15.1 16.8 4% 
  Sweden SE 52.0 55.4 61.1 70.3 5% 
  Slovenia SI 25.9 25.7 26.0 25.9 0% 
  Slovakia SK 16.1 15.9 16.5 19.5 6% 
  United Kingdom UK 52.5 57.0 66.6 68.7 1% 
Associated Albania AL 10.0 12.1 10.3 11.9 5% 
  Armenia AM 14.9 15.2 18.0 20.7 5% 
  Bosnia and Herzegovina BA 11.7 11.1 13.9 13.2 -2% 
  FYRO Macedonia MK 11.7 11.9 13.9 14.3 1% 
  Georgia GE 13.5 15.6 17.9 18.2 1% 
  Iceland IS 34.4 36.5 38.0 37.9 0% 
  Israel IL 50.8 57.5 59.5 59.9 0% 
  Moldova MD 12.5 12.7 12.6 15.4 7% 
  Montenegro ME 13.3 12.3 13.7 12.8 -2% 
  Norway NO 44.1 47.6 39.6 50.2 8% 
  Serbia RS 14.0 14.6 14.0 15.2 3% 
  Switzerland CH 80.3 86.9 98.9 97.5 0% 
  Tunisia TN 13.7 13.5 13.5 15.0 4% 
  Turkey TR 17.2 16.9 16.8 16.7 0% 
  Ukraine UA 12.5 12.4 12.0 14.3 6% 
Source: JRC Calculations. Note: CAGR = Compound annual average growth rate  
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3.1 Data reliability 
We note that countries on the ERA periphery with a low number of publications and PCT 
patents show a high degree of fluctuation for the HICIT and PCT components. We 
noticed that PCT data should be considered unreliable for some or all of the years for the 
following countries: AL, AM, BA, CY, EE, GE, LT, LV, MD, ME, MK, MT, TN. It is also 
important to note that the trend of AREI score growth over time is driven, to a large 
extent, by the expansion of the ERC program. This gives reason to treat growth over 
time with caution and use as a benchmark the compound average growth (CAGR) figures 
of the EU28.  
 
3.2 Robustness 
A strong, positive correlation was found between the components (Pearson’s coeff. 0.52-
0.72). Principal Component Analysis (PCA) confirms the presence of one single latent 
dimension that explains 72% of variance in the data (4 components, 44 countries, 4 
time points). The PCA shows a relatively balanced loading for all components, although 
the ERC component a slightly weaker. (This is also apparent from the pairwise 
correlation across the variables, presented in Table 3.) We do note at the same time 
that over time, the ERC component is showing the greatest increase, driving most of the 
overall observed growth of the composite scores.  
 
Figure 1 Adjusted Research Excellence index scores, 2018 edition 
 
Source: JRC calculations; Notes: The Research Excellence index is a composite of four components: share of 
top 10% most highly cited publications per total publications (data source: CWTS); PCT patent applications 
per population (OECD, World Bank); Participation in Marie Skłodowska-Curie Actions (DG-EAC); ERC grants 
per public R&D (DG-RTD, Eurostat, OECD). 
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Table 3 Descriptive statistics and Correlations for the components 
Descriptive Statistics 
(min-max normalized dataset)  Correlation table (N=176) 
 Mean S.D. Min Max  HICIT PCT MSCA ERC 
HICIT 0.08 0.04 0.0 0.16 
 
1 
   PCT 72.2 92.3 0.0 329.8 
 
0.71 1 
  MSCA 1.16 1.42 0.0 6.30 
 
0.72 0.66 1 
 ERC 5,375.3 7,458.2 0.0 28,290.0 
 
0.58 0.58 0.52 1 
Source: JRC calculations 
 
Similar conclusions can be drawn from the sensitivity analysis that was carried out using 
two methods to test the extent to which a component explains variation in the aggregate 
scores, which is a measure of the importance of a component.3 The sensitivity indices 
obtained from the linear method (Pearson correlation squared) and a non-linear spline 
fitting method (Table 4) shows that composite scores are driven by each of the 
component in a fairly balanced manner; with the strongest indices shown by the PCT 
component and the weakest by the ERC component. It is important to keep in mind, 
nevertheless, that while the ERC is relatively the weakest contribution to the variance in 
the results, it does have an important contribution to change over time, given the fact 
that ERC scores show a greater increasing trend over time than any of the other 
components. 
 
Table 4 Sensitivity indices 
 
Si Si 
Components Linear method Polynomial method 
HICIT 0.714 0.738 
PCT 0.776 0.811 
MSCA 0.723 0.801 
ERC 0.630 0.704 
Note: JRC calculation; components were min-max method, MSCA and ERC: outliers winsorized. Sensitivity 
indices (Si) range between 0 and 1 and show the extent to which a component drives the variation in 
composite scores. 
 
In the uncertainty analysis, we tested the impact of uncertainty in the composite 
indicator development methodology on the ranking of countries. We considered 
uncertainty in three of the modelling choices, as described below:  
 the weighting of the four components: AREI components are equally weighted; 
our tests considered a perturbation of these weights by +/- 25%; 
 the average applied: AREI is a geometric average of components, but many 
composite indicators apply the fully compensatory arithmetic average; , 
 finally, the treatment of outliers in the ERC component: as an alternative to the 
established method of treating outliers by winsorization, one may consider log-
normalizing this component given the increasing trend over time in this 
component, which is suppressed by the winsorization for the best performing 
country.  
 
 
 
 
                                           
3 For details, see Paruolo et al, 2013 and Becker et al, 2017. 
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We considered these uncertainties simultaneously, following i.e. Saisana et al (2011), 
and computed 1,000 simulated country rankings for the latest time point. The 
simulations help quantify the uncertainty by effectively adding confidence intervals to 
the baseline country rankings, as shown Figure 2. The uncertainty analysis reveals that 
the baseline rank corresponds to the median obtained from 1,000 Monte-Carlo 
simulation runs in 16 of the 44 countries ranked, and the difference is less than 3 
positions in all country cases but Georgia and Tunisia. In 93% of the cases (exc. MD, TN 
and MK), the baseline rank falls within the 90% confidence interval. Users of any index 
are discouraged to take ranks at face value given the modelling uncertainties, it is 
nevertheless important to note that the 90% interval range of the simulated ranks for 
about 19 countries is not more than 3 positions, and for another 18 countries it is not 
more than 4 positions. Ranks are relatively most volatile for Armenia, Malta, Georgia, 
Cyprus, Bulgaria and Serbia.  
 
Figure 2 Robustness of Research Excellence index ranks 
 
Source: JRC calculations; Notes: Ranks for 2016 obtained from 1,000 Monte-Carlo simulation runs 
addressing uncertainty in weights (+/-25% vs. equal), average used to aggregate scores (arithmetic vs. 
geometric), treatment of outliers in ERC (log-normal vs. winsorization).  
0
5
10
15
20
25
30
35
40
45
C
o
u
n
tr
y 
ra
n
ks
C
H
D
K
N
L
S
E
U
K IL L
U B
E F
I
A
T IE D
E
N
O F
R
E
U
2
8 IS C
Y E
S IT H
U E
E
P
T
M
T S
I
E
L
C
Z
A
M L
V
S
K
H
R
P
L
G
E
R
O T
R L
T
B
G
M
D R
S
T
N
M
K
U
A
B
A
M
E
A
L
90% interval of simulated ranks
median of simulated ranks
baseline rank
Ranks for 2016 obtained from 1000 Monte-Carlo simulations
Robustness of ranks
11 
 
4 Conclusions 
This report presented the adjusted research excellence index scores, which updates the 
scores published in the 2016 ERA Progress Report. The existing methodology remains 
applicable for the 2018 update, no further methodological adjustments were necessary.  
The multivariate analysis showed that the indicator continues to reflect a single latent 
dimension, sensitivity analysis shows a fairly balanced contribution of the four 
component to the variation of the final scores. For analysing score changes over time, 
users are reminded that most of the score increases are due to the growing trend of the 
ERC component.  
Results show that Switzerland continues to excel in having the most effective national 
research system, and that Europe shows a Northwest – Southeast divide, with also 
strong performance shown by Denmark, the Netherlands, Sweden and the United 
Kingdom. Country ranks were found to be rather robust, with uncertainty in the 
modelling choices having only limited impact (3-4 rank positions shifts) on the ranks of 
the majority of the countries. Nevertheless, users of the aggregate ranks are reminded 
that when a country rank is taken at face value, the inherent uncertainty in how it was 
obtained is not considered. The confidence intervals obtained in the uncertainty analysis 
after running 1,000 Monte-Carlo simulations serve the purpose of showing the possible 
range of research excellence ranks a country can obtain should some of the assumptions 
change. 
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Appendix: Original and Normalized Indicator scores 
   Year HICIT PCT MSCA ERC 
H2020  Nominal 2010 2011 2013 2016 2010 2011 2013 2016 2010 2011 2013 2016 2010 2011 2013 2016 
Group Actual  2009 2010 2012 2015 2009 2010 2012 2015 2011 2012 2014 2017 2010 2011 2013 2016 
EU28 EU28 10.3% 10.5% 10.5% 10.6% 95.0 97.9 100.1 102.8 1.3 1.3 1.2 1.2 3,040.5 5,018.7 9,728.6 15,054.1 
EU28 AT 10.5% 11.4% 11.0% 11.1% 153.7 168.8 166.9 177.2 1.5 1.1 0.8 2.0 3,639.0 5,766.4 10,049.5 14,852.5 
EU28 BE 12.6% 12.5% 12.9% 12.6% 106.0 114.9 107.9 108.6 1.6 1.9 2.3 2.2 3,078.6 5,180.1 12,310.4 20,019.8 
EU28 BG 4.5% 4.2% 3.6% 4.2% 3.7 4.0 7.8 8.3 0.3 0.3 0.2 0.4 1,955.7 3,031.1 3,026.4 935.7 
EU28 CY 7.0% 8.3% 7.7% 9.0% 11.0 5.5 7.3 13.6 0.9 0.8 0.8 1.0 9,950.4 13,747.0 32,612.4 41,690.3 
EU28 CZ 6.2% 6.5% 6.6% 6.6% 17.1 14.6 20.5 23.7 1.0 1.0 0.8 0.7 698.3 944.6 975.3 3,246.5 
EU28 DE 11.1% 11.5% 11.3% 11.3% 211.2 226.2 223.0 221.1 1.3 1.5 1.5 1.4 1,868.1 3,361.1 6,344.9 9,988.7 
EU28 DK 13.8% 14.1% 13.7% 13.4% 204.2 206.2 206.1 222.6 3.1 3.2 3.7 5.5 2,955.7 5,076.2 11,503.2 19,915.0 
EU28 EE 6.4% 7.5% 7.4% 8.2% 37.1 37.3 13.4 20.3 1.5 1.2 1.3 1.1 0.0 1,805.6 5,191.1 9,561.8 
EU28 EL 8.7% 8.5% 9.1% 9.0% 9.8 8.2 10.5 10.0 0.8 0.7 0.7 0.5 3,022.5 4,481.7 7,377.9 6,489.0 
EU28 ES 9.2% 9.2% 9.3% 9.3% 38.3 40.9 37.4 38.3 0.9 1.0 0.9 1.0 2,725.6 4,278.7 8,123.2 13,299.9 
EU28 FI 10.2% 10.6% 10.4% 10.8% 281.0 292.6 305.4 236.3 1.1 1.1 1.1 1.5 3,626.6 5,262.2 9,471.7 14,785.2 
EU28 FR 10.7% 10.8% 11.2% 11.0% 108.3 110.9 117.8 122.0 1.4 1.4 1.2 1.5 2,943.8 4,753.4 8,995.9 12,794.2 
EU28 HU 7.2% 7.3% 7.3% 6.9% 23.4 24.4 24.0 26.8 0.6 0.6 0.5 0.5 4,047.9 6,424.4 11,333.4 20,114.3 
EU28 HR 3.9% 3.8% 3.6% 4.6% 9.9 10.8 10.7 9.9 0.2 0.1 0.2 0.4 0.0 0.0 1,296.3 3,287.4 
EU28 IE 11.0% 11.7% 12.5% 12.6% 83.8 74.6 81.2 93.2 1.3 1.2 1.2 1.9 1,911.1 5,534.0 12,463.0 20,849.4 
EU28 IT 9.6% 9.8% 10.1% 10.4% 53.1 53.1 55.9 59.9 0.5 0.6 0.5 0.5 2,647.4 4,397.4 6,808.2 11,225.7 
EU28 LT 6.0% 7.1% 3.3% 4.3% 4.5 6.4 15.3 16.7 0.4 0.4 0.3 0.5 0.0 0.0 0.0 0.0 
EU28 LU 10.5% 13.0% 10.8% 13.1% 109.9 111.0 130.2 135.6 0.9 4.1 4.9 7.2 0.0 0.0 1,347.4 5,746.9 
EU28 LV 3.4% 3.5% 4.1% 6.2% 14.7 6.4 16.1 15.2 0.7 0.7 0.4 0.3 0.0 0.0 1,772.4 2,171.0 
EU28 MT 4.3% 5.9% 5.2% 10.7% 5.4 15.7 18.3 32.0 0.0 0.3 0.5 2.6 0.0 0.0 0.0 0.0 
EU28 NL 14.2% 14.8% 14.8% 14.6% 196.4 177.1 209.0 218.5 2.3 1.8 2.1 2.7 5,341.7 8,943.3 19,416.1 28,290.0 
EU28 PL 4.2% 4.2% 4.4% 5.1% 6.7 7.3 9.7 14.0 0.3 0.3 0.3 0.5 549.9 627.7 1,247.7 1,704.4 
EU28 PT 9.3% 8.8% 9.4% 9.0% 13.2 12.8 13.8 21.2 0.7 0.9 0.6 0.7 1,512.4 2,556.9 4,880.9 11,134.7 
EU28 RO 4.3% 4.1% 5.2% 4.8% 2.1 2.1 3.2 3.8 0.2 0.2 0.2 0.4 0.0 0.0 0.0 1,276.0 
EU28 SE 11.7% 11.8% 11.6% 12.1% 306.2 303.6 329.8 329.1 2.1 2.0 2.0 3.3 5,165.9 8,144.0 12,652.3 14,536.4 
EU28 SI 7.5% 8.0% 8.7% 8.6% 64.1 65.7 61.3 40.0 1.3 1.0 0.6 0.7 511.5 824.1 1,860.4 2,959.4 
EU28 SK 5.7% 5.2% 5.1% 6.2% 6.7 9.1 8.4 11.2 0.3 0.3 0.3 0.9 0.0 0.0 516.2 532.3 
EU28 UK 13.8% 14.1% 14.2% 15.0% 91.2 91.7 90.5 96.5 5.4 4.8 4.8 3.9 5,993.5 10,449.2 22,116.4 34,606.6 
Associated AL 1.1% 2.8% 1.2% 2.1% 0.3 0.3 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 
Associated AM 7.0% 7.7% 15.4% 11.6% 2.1 1.7 2.7 2.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 
Associated BA 2.3% 1.8% 4.1% 3.3% 2.3 1.4 2.2 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 
Associated MK 1.8% 2.2% 4.9% 6.1% 1.4 0.0 0.2 0.8 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 
Associated GE 4.7% 8.5% 15.0% 11.3% 1.3 2.0 2.8 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 
Associated IS 8.9% 13.6% 10.6% 10.8% 111.8 85.4 103.5 117.4 1.3 1.3 1.5 1.4 3,415.6 3,648.1 4,879.1 4,390.7 
Associated IL 9.5% 10.0% 10.3% 10.0% 225.8 222.5 254.6 267.1 1.0 1.1 1.0 1.0 16,994.0 26,926.4 49,229.4 70,615.5 
Associated MD 3.3% 3.6% 3.4% 4.7% 0.5 0.5 1.0 1.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 
Associated ME 3.8% 2.6% 4.9% 3.2% 6.5 6.5 1.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Associated NO 11.1% 10.9% 11.1% 10.7% 155.0 150.6 142.0 125.5 3.4 3.5 0.8 3.2 2,319.2 4,520.5 7,251.1 8,861.4 
Associated RS 4.6% 5.4% 4.4% 4.1% 3.2 2.8 3.9 4.9 0.1 0.1 0.1 0.2 0.0 0.0 0.0 782.6 
Associated CH 15.3% 15.1% 15.5% 15.3% 287.8 301.6 328.4 310.9 6.8 7.2 7.6 6.3 12,335.9 17,601.7 28,100.0 35,370.1 
Associated TN 5.1% 4.6% 4.7% 5.8% 0.9 1.5 0.6 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 
Associated TR 5.6% 5.1% 4.8% 4.7% 6.5 7.7 8.8 13.7 0.6 0.6 0.6 0.3 39.7 36.1 155.9 677.3 
Associated UA 3.2% 2.9% 2.5% 3.6% 2.3 3.5 3.9 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 
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Appendix (cont’d): Normalized Scores 
 HICIT PCT MSCA ERC 
 2010 2011 2013 2016 2010 2011 2013 2016 2010 2011 2013 2016 2010 2011 2013 2016 
 2009 2010 2012 2015 2009 2010 2012 2015 2011 2012 2014 2017 2010 2011 2013 2016 
EU28 67.2 68.4 68.6 69.0 34.9 68.4 36.3 37.0 28.1 35.7 27.6 27.8 19.7 28.1 41.0 57.9 
AT 68.9 74.5 71.5 72.6 50.3 74.5 53.8 56.5 31.8 54.3 22.1 38.8 21.6 26.2 42.0 57.3 
BE 81.4 81.3 83.7 81.5 37.8 81.3 38.3 38.5 33.3 40.1 43.3 42.1 19.8 37.6 49.2 73.7 
BG 31.6 29.4 25.9 29.4 11.0 29.4 12.1 12.2 13.9 11.0 12.6 16.4 16.2 13.7 19.6 13.0 
CY 46.9 54.7 51.2 59.2 12.9 54.7 11.9 13.6 23.0 11.4 21.2 23.6 41.7 21.6 100.0 100.0 
CZ 42.1 44.0 44.5 44.5 14.5 44.0 15.4 16.2 25.0 13.8 22.0 19.6 12.2 25.0 13.1 20.3 
DE 72.3 74.8 73.8 73.8 65.4 74.8 68.5 68.0 28.2 69.3 30.7 30.6 15.9 31.1 30.2 41.8 
DK 89.0 91.3 88.8 86.4 63.6 91.3 64.1 68.4 54.6 64.1 63.3 88.0 19.4 55.1 46.6 73.4 
EE 43.4 49.7 49.5 54.6 19.7 49.7 13.5 15.3 31.0 19.8 28.1 25.3 10.0 26.9 26.5 40.4 
EL 57.4 56.1 59.9 59.5 12.6 56.1 12.8 12.6 21.3 12.1 19.7 17.5 19.6 19.7 33.5 30.6 
ES 60.7 60.8 61.1 61.1 20.0 60.8 19.8 20.0 22.3 20.7 23.1 23.7 18.7 23.7 35.8 52.3 
FI 67.0 69.2 68.0 70.7 83.7 69.2 90.1 72.0 25.6 86.7 26.4 31.4 21.5 25.4 40.1 57.0 
FR 70.1 70.6 72.8 71.7 38.4 70.6 40.9 42.0 29.4 39.1 27.8 30.9 19.4 30.0 38.6 50.7 
HU 48.3 48.5 49.0 46.3 16.1 48.5 16.3 17.0 18.5 16.4 17.4 16.8 22.9 18.9 46.1 74.0 
HR 27.3 26.9 26.0 32.2 12.6 26.9 12.8 12.6 12.9 12.8 12.3 15.9 10.0 12.0 14.1 20.5 
IE 71.5 76.3 81.3 81.4 32.0 76.3 31.3 34.5 28.6 29.6 27.4 36.5 16.1 26.5 49.6 76.3 
IT 63.1 64.4 66.1 68.2 23.9 64.4 24.7 25.7 17.8 23.9 17.8 17.4 18.4 18.2 31.7 45.7 
LT 40.4 47.5 23.9 30.1 11.2 47.5 14.0 14.4 15.1 11.7 13.8 17.8 10.0 16.1 10.0 10.0 
LU 68.5 84.1 70.7 84.5 38.8 84.1 44.2 45.6 22.2 39.1 80.3 100.0 10.0 68.3 14.3 28.3 
LV 24.2 25.3 28.7 41.9 13.8 25.3 14.2 14.0 19.5 11.7 15.6 14.9 10.0 19.5 15.6 16.9 
MT 29.9 40.0 35.8 69.8 11.4 40.0 14.8 18.4 10.0 14.1 16.6 46.5 10.0 14.1 10.0 10.0 
NL 91.7 95.5 95.6 94.0 61.5 95.5 64.8 67.3 43.0 56.5 40.5 48.6 27.0 36.0 71.8 100.0 
PL 29.4 29.5 30.5 34.8 11.8 29.5 12.5 13.7 14.3 11.9 14.1 16.8 11.7 14.2 14.0 15.4 
PT 61.3 58.2 62.0 59.5 13.5 58.2 13.6 15.6 20.4 13.4 19.0 19.6 14.8 22.3 25.5 45.4 
RO 29.9 28.9 36.0 33.2 10.6 28.9 10.8 11.0 13.1 10.5 13.4 15.4 10.0 13.1 10.0 14.1 
SE 75.8 76.6 75.7 78.5 90.3 76.6 96.5 96.3 40.5 89.6 38.1 57.4 26.4 38.1 50.3 56.2 
SI 49.8 53.2 57.7 56.5 26.8 53.2 26.1 20.5 29.0 27.2 19.1 20.0 11.6 24.0 15.9 19.4 
SK 38.6 35.4 35.3 41.8 11.8 35.4 12.2 12.9 14.7 12.4 14.8 22.7 10.0 14.6 11.6 11.7 
UK 89.3 91.0 91.8 96.5 33.9 91.0 33.7 35.3 86.6 34.1 79.1 65.4 29.1 78.6 80.4 100.0 
AL 10.0 21.1 11.0 16.3 10.1 21.1 10.1 10.0 10.0 10.1 10.0 12.5 10.0 10.0 10.0 10.0 
AM 46.6 50.9 98.9 75.1 10.6 50.9 10.7 10.7 10.0 10.4 10.0 22.9 10.0 10.0 10.0 10.0 
BA 17.6 14.6 28.7 23.9 10.6 14.6 10.6 10.4 10.0 10.4 12.4 12.0 10.0 10.0 10.0 10.0 
MK 14.4 16.7 33.9 41.2 10.4 16.7 10.1 10.2 12.4 10.0 10.8 10.0 10.0 11.8 10.0 10.0 
GE 32.3 56.2 96.6 73.5 10.3 56.2 10.7 10.2 10.0 10.5 10.0 14.8 10.0 10.0 10.0 10.0 
IS 58.4 87.7 69.0 70.5 39.3 87.7 37.2 40.8 29.0 32.4 31.8 30.0 20.9 29.0 25.5 24.0 
IL 62.5 65.7 67.1 65.7 69.2 65.7 76.8 80.0 24.1 68.3 24.3 24.4 64.1 25.4 100.0 100.0 
MD 23.9 25.6 24.2 32.4 10.1 25.6 10.3 10.4 10.0 10.1 10.0 16.6 10.0 10.0 10.0 10.0 
ME 27.0 19.6 33.9 23.4 11.7 19.6 10.4 11.3 10.0 11.7 10.0 10.0 10.0 10.0 10.0 10.0 
NO 72.5 70.9 72.3 70.0 50.6 70.9 47.3 42.9 59.1 49.5 21.7 55.3 17.4 60.0 33.1 38.2 
RS 32.2 36.9 30.6 29.0 10.8 36.9 11.0 11.3 11.1 10.7 11.4 12.9 10.0 11.6 10.0 12.5 
CH 98.5 97.1 100.0 98.6 85.5 97.1 96.1 91.5 100.0 89.1 100.0 100.0 49.2 100.0 99.4 100.0 
TN 34.8 31.7 32.6 39.3 10.2 31.7 10.2 10.3 10.0 10.4 10.0 12.5 10.0 10.0 10.0 10.0 
TR 38.3 35.0 33.3 32.6 11.7 35.0 12.3 13.6 19.1 12.0 18.4 14.4 10.1 19.3 10.5 12.2 
UA 23.3 21.4 18.7 25.8 10.6 21.4 11.0 10.9 10.0 10.9 10.0 14.7 10.0 10.0 10.0 10.0 
GETTING IN TOUCH WITH THE EU 
In person 
All over the European Union there are hundreds of Europe Direct information centres. You can find the 
address of the centre nearest you at: https://europa.eu/european-union/contact_en 
On the phone or by email 
Europe Direct is a service that answers your questions about the European Union. You can contact this 
service: 
- by freephone: 00 800 6 7 8 9 10 11 (certain operators may charge for these calls), 
- at the following standard number: +32 22999696, or 
- by electronic mail via: https://europa.eu/european-union/contact_en 
FINDING INFORMATION ABOUT THE EU 
Online 
Information about the European Union in all the official languages of the EU is available on the Europa 
website at: https://europa.eu/european-union/index_en 
EU publications 
You can download or order free and priced EU publications from EU Bookshop at: 
https://publications.europa.eu/en/publications. Multiple copies of free publications may be obtained by 
contacting Europe Direct or your local information centre (see https://europa.eu/european-
union/contact_en). 
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